Baxter (BAX) Tops Q4 EPS by 2c, Offers Guidance

Baxter (NYSE: BAX) reported Q4 EPS of $0.88, $0.02 better than the analyst estimate of $0.86. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.81 billion.

GUIDANCE:

Baxter sees FY2024 EPS of $2.85-$2.95, versus the consensus of $2.93.

Baxter sees Q1 2024 EPS of $0.59-$0.62, versus the consensus of $0.62.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance